Quick Answer
BIOLIFE SOLUTIONS INC reported Net Income Loss of -$4.60 million for the year ending 2025.
- BIOLIFE SOLUTIONS INC showed an increase of +77.2% in Net Income Loss from 2024 to 2025.
- This data is from BIOLIFE SOLUTIONS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: -$296.9 thousand | Q2 2012: -$498.9 thousand | Q3 2012: -$352.2 thousand | Q1 2013: -$7.2 thousand | Q2 2013: -$282.5 thousand | Q3 2013: -$309.9 thousand | Q1 2014: -$559.4 thousand | Q2 2014: -$883.4 thousand | Q3 2014: -$862.5 thousand | Q1 2015: -$1.03 million | Q2 2015: -$994.4 thousand | Q3 2015: -$1.07 million | Q1 2016: -$1.23 million | Q2 2016: -$1.36 million | Q3 2016: -$969.0 thousand | Q1 2017: -$870.3 thousand | Q2 2017: -$768.2 thousand | Q3 2017: -$318.7 thousand | Q1 2018: $4.87 million | Q2 2018: -$26.35 million | Q3 2018: -$24.47 million | Q1 2019: -$19.16 million | Q2 2019: $4.25 million | Q3 2019: $10.27 million | Q1 2020: $22.31 million | Q2 2020: -$16.38 million | Q3 2020: -$1.13 million | Q1 2021: -$1.12 million | Q2 2021: $7.88 million | Q3 2021: $79.0 thousand | Q1 2022: -$7.42 million | Q2 2022: -$72.88 million | Q3 2022: -$10.32 million | Q1 2023: -$13.71 million | Q2 2023: -$10.20 million | Q3 2023: -$29.13 million | Q1 2024: -$10.22 million | Q2 2024: -$20.72 million | Q3 2024: -$1.70 million | Q1 2025: -$448.0 thousand | Q2 2025: -$15.84 million | Q3 2025: $621.0 thousand.
- Over the full 16 years of available data (2010 to 2025), BIOLIFE SOLUTIONS INC's Net Income Loss has declined by 131.6%.
- Historical annual values: Fiscal year 2025: -$4.60 million | Fiscal year 2024: -$20.18 million | Fiscal year 2023: -$68.00 million | Fiscal year 2022: -$139.81 million | Fiscal year 2021: -$8.91 million | Fiscal year 2020: $1.98 million | Fiscal year 2019: -$1.66 million | Fiscal year 2018: -$25.01 million | Fiscal year 2017: -$2.52 million | Fiscal year 2016: -$6.88 million | Fiscal year 2015: -$4.21 million | Fiscal year 2014: -$3.22 million | Fiscal year 2013: -$1.08 million | Fiscal year 2012: -$1.66 million | Fiscal year 2011: -$1.96 million | Fiscal year 2010: -$1.98 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: